Denosumab for the Prevention of Skeletal-Related Events in Patients with Bone Metastasis from Solid Tumor-Reference-Cited by-同舟云学术

Denosumab for the Prevention of Skeletal-Related Events in Patients with Bone Metastasis from Solid Tumor

Published:2012-02-13 Issue:3 Volume:32 Page:274-284
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Iranikhah Maryam¹,Wilborn Teresa W.¹,Wensel Terri M.¹,Ferrell Jodi B.¹

Affiliation:

1. Samford University McWhorter School of Pharmacy; Birmingham; Alabama

Publisher

Wiley

Subject

Pharmacology (medical)

Reference46 articles.

1. Pharmacologic prevention of skeletal-related events in cancer patients;Bottiglieri;Orthopedics,2010

2. Pathologic fractures correlate with reduced survival in patients with malignant bone disease;Saad;Cancer,2007

3. Bones, breasts, and bisphosphonates: rationale for the use of zoledronic acid in advanced and early breast cancer;Lipton;Breast Cancer: Targets Therapy,2011

4. Incidence of bone metastases and skeletal-related events in breast cancer patients: a population-based cohort study in Denmark;Jensen;BMC Cancer,2011

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the therapeutic promise: exploring Lysophosphatidic Acid (LPA) signaling in malignant bone tumors for novel cancer treatments;Lipids in Health and Disease;2024-06-28

2. RANK Expression as an Independent Predictor for Response to Neoadjuvant Chemotherapy in Luminal-Like Breast Cancer: A Translational Insight from the GeparX Trial;Clinical Cancer Research;2023-09-19

3. The RANK/RANKL/OPG system and tumor bone metastasis: Potential mechanisms and therapeutic strategies;Frontiers in Endocrinology;2022-12-16

4. Regulatory mechanism of Scutellaria baicalensis Georgi on bone cancer pain based on network pharmacology and experimental verification;PeerJ;2022-11-17

5. Effect of Denosumab Added to 2 Different nab-Paclitaxel Regimens as Neoadjuvant Therapy in Patients With Primary Breast Cancer;JAMA Oncology;2022-07-01